Anticancer agent 31

Anticancer agent 31 is a 1,3-diphenylurea quinoxaline derivative that exerts antitumor activity by inducing S-phase cell cycle arrest and apoptosis. It has demonstrated efficacy in both in vitro cytotoxicity assays and in vivo xenograft models, supporting its investigation as a potential chemotherapeutic agent.